Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study
GB Pajno, L Caminiti, D Vita, G Barberio… - Journal of Allergy and …, 2007 - Elsevier
BACKGROUND: Atopic dermatitis often has an allergic component, and immunotherapy
may therefore prove beneficial. OBJECTIVE: To assess the effect of sublingual
immunotherapy (SLIT) in children with atopic dermatitis. METHODS: Children age 5 to 16
years with atopic dermatitis (Scoring Atopic Dermatitis [SCORAD]> 7) and sensitization to
dust mites alone, without food allergy or chronic asthma, were enrolled in a randomized,
double-blind, placebo-controlled study and stratified according to disease severity. SLIT or …
may therefore prove beneficial. OBJECTIVE: To assess the effect of sublingual
immunotherapy (SLIT) in children with atopic dermatitis. METHODS: Children age 5 to 16
years with atopic dermatitis (Scoring Atopic Dermatitis [SCORAD]> 7) and sensitization to
dust mites alone, without food allergy or chronic asthma, were enrolled in a randomized,
double-blind, placebo-controlled study and stratified according to disease severity. SLIT or …
